Drug Class
GLP-1 peptides
Glucagon-like peptide-1 receptor agonist
About the GLP-1 class
9 peptides on PeptideHelper.org are tagged with this class.
Class assignments are editorial; some peptides span multiple mechanism classes. Most peptides catalogued are not FDA-approved for human use.
Peptides in this class (9)
- Tirzepatide , GIP/GLP-1 dual incretin agonist · FDA-Approved · Prescription · 262 citations
- Semaglutide , GLP-1 receptor agonist · FDA-Approved · Prescription · 258 citations
- Retatrutide , GIP/GLP-1/glucagon triple agonist · Phase 3 · Investigational · 198 citations
- Dulaglutide , GLP-1 receptor agonist · FDA-Approved · Prescription · 258 citations
- Liraglutide , GLP-1 receptor agonist · FDA-Approved · Prescription · 258 citations
- Mazdutide , GLP-1/glucagon dual agonist · Phase 3 (China) · Investigational · 112 citations
- Survodutide , GLP-1/glucagon dual agonist · Phase 3 · Investigational · 124 citations
- Orforglipron , Oral non-peptide GLP-1 agonist · FDA-Approved · Prescription · 157 citations
- CagriSema , Amylin + GLP-1 combination · Phase 3 · Investigational · 108 citations
Frequently asked questions
What is a GLP-1 peptide?
Glucagon-like peptide-1 receptor agonist
Which peptides are in the GLP-1 class?
9 peptides catalogued on PeptideHelper.org are tagged GLP-1: Tirzepatide, Semaglutide, Retatrutide, Dulaglutide, Liraglutide, Mazdutide, Survodutide, Orforglipron, CagriSema.
Are any GLP-1 peptides FDA-approved?
5 GLP-1 peptides are FDA-approved on PeptideHelper.org's catalog: Tirzepatide, Semaglutide, Dulaglutide, Liraglutide, Orforglipron.
Browse the full PeptideHelper.org catalog with filters for evidence tier, regulatory status, and goal area.
Loading interactive view…